ACTA DIABETOLOGICA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1085993, encodeId=82c0108599362, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591256, encodeId=1381591256ff, content=请问投稿一定要用La Tex吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f11510682, createdName=baoyan713, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579362, encodeId=de995e9362ef, content=同问我的感觉直接变成Under Review了nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5215161402, createdName=壹贰叁, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577697, encodeId=d0f95e769726, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：8号投稿，10号拒稿，处理速度快，不符合杂志要求不会拖延时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30ed1655028, createdName=Yyy8770, createdTime=Fri Oct 11 00:00:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847446, encodeId=2a9284e446c0, content=虽然还是内分泌学中比较一般的期刊，不过还是可以考虑投的，比较分还挺高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Sep 27 10:56:40 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560556, encodeId=ced456055673, content=请问后面都不接受meta分析了吗？biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, beContent=biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677a2417574, createdName=1238c4bem36暂无昵称, createdTime=Wed Aug 29 00:00:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559953, encodeId=463d5599536c, content=刚投的话应该是submitted to journal但很快就变成with editor，再变成under reviewnfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559758, encodeId=5193559e5827, content=请问这个杂志刚投稿成功状态就成为Under Review吗？136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。136****9922暂无昵称 2018-07-26 00:00:00 发表: 刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b781481343, createdName=nfm123, createdTime=Wed Aug 01 00:00:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559592, encodeId=b74c5595923b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Thu Jul 26 00:00:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530597, encodeId=a01753059e3a, content=投稿命中率:25.0 经验分享：刚投稿一篇，稿件号584，近2年发文290篇，推算接收率约25%。期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d8d1638454, createdName=empire253, createdTime=Wed Dec 14 16:41:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2021-12-27 MS54455111222

讨论中一般可以讨论什么？

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1085993, encodeId=82c0108599362, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591256, encodeId=1381591256ff, content=请问投稿一定要用La Tex吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f11510682, createdName=baoyan713, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579362, encodeId=de995e9362ef, content=同问我的感觉直接变成Under Review了nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5215161402, createdName=壹贰叁, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577697, encodeId=d0f95e769726, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：8号投稿，10号拒稿，处理速度快，不符合杂志要求不会拖延时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30ed1655028, createdName=Yyy8770, createdTime=Fri Oct 11 00:00:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847446, encodeId=2a9284e446c0, content=虽然还是内分泌学中比较一般的期刊，不过还是可以考虑投的，比较分还挺高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Sep 27 10:56:40 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560556, encodeId=ced456055673, content=请问后面都不接受meta分析了吗？biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, beContent=biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677a2417574, createdName=1238c4bem36暂无昵称, createdTime=Wed Aug 29 00:00:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559953, encodeId=463d5599536c, content=刚投的话应该是submitted to journal但很快就变成with editor，再变成under reviewnfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559758, encodeId=5193559e5827, content=请问这个杂志刚投稿成功状态就成为Under Review吗？136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。136****9922暂无昵称 2018-07-26 00:00:00 发表: 刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b781481343, createdName=nfm123, createdTime=Wed Aug 01 00:00:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559592, encodeId=b74c5595923b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Thu Jul 26 00:00:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530597, encodeId=a01753059e3a, content=投稿命中率:25.0 经验分享：刚投稿一篇，稿件号584，近2年发文290篇，推算接收率约25%。期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d8d1638454, createdName=empire253, createdTime=Wed Dec 14 16:41:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2020-05-19 baoyan713

请问投稿一定要用La Tex吗

136 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1085993, encodeId=82c0108599362, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591256, encodeId=1381591256ff, content=请问投稿一定要用La Tex吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f11510682, createdName=baoyan713, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579362, encodeId=de995e9362ef, content=同问我的感觉直接变成Under Review了nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5215161402, createdName=壹贰叁, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577697, encodeId=d0f95e769726, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：8号投稿，10号拒稿，处理速度快，不符合杂志要求不会拖延时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30ed1655028, createdName=Yyy8770, createdTime=Fri Oct 11 00:00:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847446, encodeId=2a9284e446c0, content=虽然还是内分泌学中比较一般的期刊，不过还是可以考虑投的，比较分还挺高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Sep 27 10:56:40 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560556, encodeId=ced456055673, content=请问后面都不接受meta分析了吗？biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, beContent=biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677a2417574, createdName=1238c4bem36暂无昵称, createdTime=Wed Aug 29 00:00:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559953, encodeId=463d5599536c, content=刚投的话应该是submitted to journal但很快就变成with editor，再变成under reviewnfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559758, encodeId=5193559e5827, content=请问这个杂志刚投稿成功状态就成为Under Review吗？136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。136****9922暂无昵称 2018-07-26 00:00:00 发表: 刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b781481343, createdName=nfm123, createdTime=Wed Aug 01 00:00:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559592, encodeId=b74c5595923b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Thu Jul 26 00:00:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530597, encodeId=a01753059e3a, content=投稿命中率:25.0 经验分享：刚投稿一篇，稿件号584，近2年发文290篇，推算接收率约25%。期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d8d1638454, createdName=empire253, createdTime=Wed Dec 14 16:41:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2019-11-04 壹贰叁

同问我的感觉直接变成Under Review了nfm123 2018-08-01 发表::
请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表:
请问这个杂志刚投稿成功状态就成为Under Review吗？

nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？

159 0

[GetPortalCommentsPageByObjectIdResponse(id=1085993, encodeId=82c0108599362, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591256, encodeId=1381591256ff, content=请问投稿一定要用La Tex吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f11510682, createdName=baoyan713, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579362, encodeId=de995e9362ef, content=同问我的感觉直接变成Under Review了nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5215161402, createdName=壹贰叁, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577697, encodeId=d0f95e769726, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：8号投稿，10号拒稿，处理速度快，不符合杂志要求不会拖延时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30ed1655028, createdName=Yyy8770, createdTime=Fri Oct 11 00:00:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847446, encodeId=2a9284e446c0, content=虽然还是内分泌学中比较一般的期刊，不过还是可以考虑投的，比较分还挺高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Sep 27 10:56:40 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560556, encodeId=ced456055673, content=请问后面都不接受meta分析了吗？biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, beContent=biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677a2417574, createdName=1238c4bem36暂无昵称, createdTime=Wed Aug 29 00:00:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559953, encodeId=463d5599536c, content=刚投的话应该是submitted to journal但很快就变成with editor，再变成under reviewnfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559758, encodeId=5193559e5827, content=请问这个杂志刚投稿成功状态就成为Under Review吗？136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。136****9922暂无昵称 2018-07-26 00:00:00 发表: 刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b781481343, createdName=nfm123, createdTime=Wed Aug 01 00:00:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559592, encodeId=b74c5595923b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Thu Jul 26 00:00:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530597, encodeId=a01753059e3a, content=投稿命中率:25.0 经验分享：刚投稿一篇，稿件号584，近2年发文290篇，推算接收率约25%。期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d8d1638454, createdName=empire253, createdTime=Wed Dec 14 16:41:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2019-10-11 Yyy8770

审稿速度:1.0 | 投稿命中率:5.0
经验分享：8号投稿，10号拒稿，处理速度快，不符合杂志要求不会拖延时间

158 0

[GetPortalCommentsPageByObjectIdResponse(id=1085993, encodeId=82c0108599362, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591256, encodeId=1381591256ff, content=请问投稿一定要用La Tex吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f11510682, createdName=baoyan713, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579362, encodeId=de995e9362ef, content=同问我的感觉直接变成Under Review了nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5215161402, createdName=壹贰叁, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577697, encodeId=d0f95e769726, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：8号投稿，10号拒稿，处理速度快，不符合杂志要求不会拖延时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30ed1655028, createdName=Yyy8770, createdTime=Fri Oct 11 00:00:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847446, encodeId=2a9284e446c0, content=虽然还是内分泌学中比较一般的期刊，不过还是可以考虑投的，比较分还挺高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Sep 27 10:56:40 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560556, encodeId=ced456055673, content=请问后面都不接受meta分析了吗？biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, beContent=biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677a2417574, createdName=1238c4bem36暂无昵称, createdTime=Wed Aug 29 00:00:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559953, encodeId=463d5599536c, content=刚投的话应该是submitted to journal但很快就变成with editor，再变成under reviewnfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559758, encodeId=5193559e5827, content=请问这个杂志刚投稿成功状态就成为Under Review吗？136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。136****9922暂无昵称 2018-07-26 00:00:00 发表: 刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b781481343, createdName=nfm123, createdTime=Wed Aug 01 00:00:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559592, encodeId=b74c5595923b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Thu Jul 26 00:00:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530597, encodeId=a01753059e3a, content=投稿命中率:25.0 经验分享：刚投稿一篇，稿件号584，近2年发文290篇，推算接收率约25%。期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d8d1638454, createdName=empire253, createdTime=Wed Dec 14 16:41:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2018-09-27 ms9574107592528786

虽然还是内分泌学中比较一般的期刊，不过还是可以考虑投的，比较分还挺高

117 0

[GetPortalCommentsPageByObjectIdResponse(id=1085993, encodeId=82c0108599362, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591256, encodeId=1381591256ff, content=请问投稿一定要用La Tex吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f11510682, createdName=baoyan713, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579362, encodeId=de995e9362ef, content=同问我的感觉直接变成Under Review了nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5215161402, createdName=壹贰叁, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577697, encodeId=d0f95e769726, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：8号投稿，10号拒稿，处理速度快，不符合杂志要求不会拖延时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30ed1655028, createdName=Yyy8770, createdTime=Fri Oct 11 00:00:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847446, encodeId=2a9284e446c0, content=虽然还是内分泌学中比较一般的期刊，不过还是可以考虑投的，比较分还挺高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Sep 27 10:56:40 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560556, encodeId=ced456055673, content=请问后面都不接受meta分析了吗？biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, beContent=biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677a2417574, createdName=1238c4bem36暂无昵称, createdTime=Wed Aug 29 00:00:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559953, encodeId=463d5599536c, content=刚投的话应该是submitted to journal但很快就变成with editor，再变成under reviewnfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559758, encodeId=5193559e5827, content=请问这个杂志刚投稿成功状态就成为Under Review吗？136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。136****9922暂无昵称 2018-07-26 00:00:00 发表: 刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b781481343, createdName=nfm123, createdTime=Wed Aug 01 00:00:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559592, encodeId=b74c5595923b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Thu Jul 26 00:00:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530597, encodeId=a01753059e3a, content=投稿命中率:25.0 经验分享：刚投稿一篇，稿件号584，近2年发文290篇，推算接收率约25%。期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d8d1638454, createdName=empire253, createdTime=Wed Dec 14 16:41:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2018-08-29 1238c4bem36暂无昵称

请问后面都不接受meta分析了吗？biosdvet 2012-06-11 13:36:00 发表:
2012.6.9 reject 不接收meta-analysis 了

biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了

287 0

[GetPortalCommentsPageByObjectIdResponse(id=1085993, encodeId=82c0108599362, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591256, encodeId=1381591256ff, content=请问投稿一定要用La Tex吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f11510682, createdName=baoyan713, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579362, encodeId=de995e9362ef, content=同问我的感觉直接变成Under Review了nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5215161402, createdName=壹贰叁, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577697, encodeId=d0f95e769726, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：8号投稿，10号拒稿，处理速度快，不符合杂志要求不会拖延时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30ed1655028, createdName=Yyy8770, createdTime=Fri Oct 11 00:00:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847446, encodeId=2a9284e446c0, content=虽然还是内分泌学中比较一般的期刊，不过还是可以考虑投的，比较分还挺高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Sep 27 10:56:40 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560556, encodeId=ced456055673, content=请问后面都不接受meta分析了吗？biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, beContent=biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677a2417574, createdName=1238c4bem36暂无昵称, createdTime=Wed Aug 29 00:00:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559953, encodeId=463d5599536c, content=刚投的话应该是submitted to journal但很快就变成with editor，再变成under reviewnfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559758, encodeId=5193559e5827, content=请问这个杂志刚投稿成功状态就成为Under Review吗？136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。136****9922暂无昵称 2018-07-26 00:00:00 发表: 刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b781481343, createdName=nfm123, createdTime=Wed Aug 01 00:00:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559592, encodeId=b74c5595923b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Thu Jul 26 00:00:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530597, encodeId=a01753059e3a, content=投稿命中率:25.0 经验分享：刚投稿一篇，稿件号584，近2年发文290篇，推算接收率约25%。期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d8d1638454, createdName=empire253, createdTime=Wed Dec 14 16:41:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2018-08-08 121a0c15m22暂无昵称

刚投的话应该是submitted to journal但很快就变成with editor，再变成under reviewnfm123 2018-08-01 发表::
请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表:
请问这个杂志刚投稿成功状态就成为Under Review吗？

nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？

295 0

[GetPortalCommentsPageByObjectIdResponse(id=1085993, encodeId=82c0108599362, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591256, encodeId=1381591256ff, content=请问投稿一定要用La Tex吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f11510682, createdName=baoyan713, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579362, encodeId=de995e9362ef, content=同问我的感觉直接变成Under Review了nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5215161402, createdName=壹贰叁, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577697, encodeId=d0f95e769726, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：8号投稿，10号拒稿，处理速度快，不符合杂志要求不会拖延时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30ed1655028, createdName=Yyy8770, createdTime=Fri Oct 11 00:00:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847446, encodeId=2a9284e446c0, content=虽然还是内分泌学中比较一般的期刊，不过还是可以考虑投的，比较分还挺高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Sep 27 10:56:40 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560556, encodeId=ced456055673, content=请问后面都不接受meta分析了吗？biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, beContent=biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677a2417574, createdName=1238c4bem36暂无昵称, createdTime=Wed Aug 29 00:00:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559953, encodeId=463d5599536c, content=刚投的话应该是submitted to journal但很快就变成with editor，再变成under reviewnfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559758, encodeId=5193559e5827, content=请问这个杂志刚投稿成功状态就成为Under Review吗？136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。136****9922暂无昵称 2018-07-26 00:00:00 发表: 刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b781481343, createdName=nfm123, createdTime=Wed Aug 01 00:00:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559592, encodeId=b74c5595923b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Thu Jul 26 00:00:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530597, encodeId=a01753059e3a, content=投稿命中率:25.0 经验分享：刚投稿一篇，稿件号584，近2年发文290篇，推算接收率约25%。期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d8d1638454, createdName=empire253, createdTime=Wed Dec 14 16:41:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2018-08-01 nfm123

请问这个杂志刚投稿成功状态就成为Under Review吗？136****9922暂无昵称 2018-07-26 发表::
接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。136****9922暂无昵称 2018-07-26 00:00:00 发表:
刚刚中了一篇，好开心。糖尿病视网膜病变的。

136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。

370 0

[GetPortalCommentsPageByObjectIdResponse(id=1085993, encodeId=82c0108599362, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591256, encodeId=1381591256ff, content=请问投稿一定要用La Tex吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f11510682, createdName=baoyan713, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579362, encodeId=de995e9362ef, content=同问我的感觉直接变成Under Review了nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5215161402, createdName=壹贰叁, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577697, encodeId=d0f95e769726, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：8号投稿，10号拒稿，处理速度快，不符合杂志要求不会拖延时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30ed1655028, createdName=Yyy8770, createdTime=Fri Oct 11 00:00:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847446, encodeId=2a9284e446c0, content=虽然还是内分泌学中比较一般的期刊，不过还是可以考虑投的，比较分还挺高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Sep 27 10:56:40 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560556, encodeId=ced456055673, content=请问后面都不接受meta分析了吗？biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, beContent=biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677a2417574, createdName=1238c4bem36暂无昵称, createdTime=Wed Aug 29 00:00:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559953, encodeId=463d5599536c, content=刚投的话应该是submitted to journal但很快就变成with editor，再变成under reviewnfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559758, encodeId=5193559e5827, content=请问这个杂志刚投稿成功状态就成为Under Review吗？136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。136****9922暂无昵称 2018-07-26 00:00:00 发表: 刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b781481343, createdName=nfm123, createdTime=Wed Aug 01 00:00:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559592, encodeId=b74c5595923b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Thu Jul 26 00:00:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530597, encodeId=a01753059e3a, content=投稿命中率:25.0 经验分享：刚投稿一篇，稿件号584，近2年发文290篇，推算接收率约25%。期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d8d1638454, createdName=empire253, createdTime=Wed Dec 14 16:41:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2018-07-26 121a0c15m22暂无昵称

审稿速度:2.0 | 投稿命中率:25.0
经验分享：刚刚中了一篇，好开心。糖尿病视网膜病变的。

207 0

[GetPortalCommentsPageByObjectIdResponse(id=1085993, encodeId=82c0108599362, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591256, encodeId=1381591256ff, content=请问投稿一定要用La Tex吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56f11510682, createdName=baoyan713, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579362, encodeId=de995e9362ef, content=同问我的感觉直接变成Under Review了nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5215161402, createdName=壹贰叁, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577697, encodeId=d0f95e769726, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：8号投稿，10号拒稿，处理速度快，不符合杂志要求不会拖延时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30ed1655028, createdName=Yyy8770, createdTime=Fri Oct 11 00:00:00 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847446, encodeId=2a9284e446c0, content=虽然还是内分泌学中比较一般的期刊，不过还是可以考虑投的，比较分还挺高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Sep 27 10:56:40 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560556, encodeId=ced456055673, content=请问后面都不接受meta分析了吗？biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, beContent=biosdvet 2012-06-11 13:36:00 发表: 2012.6.9 reject 不接收meta-analysis 了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677a2417574, createdName=1238c4bem36暂无昵称, createdTime=Wed Aug 29 00:00:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559953, encodeId=463d5599536c, content=刚投的话应该是submitted to journal但很快就变成with editor，再变成under reviewnfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？nfm123 2018-08-01 00:00:00 发表: 请问这个杂志刚投稿成功状态就成为Under Review吗？, beContent=nfm123 2018-08-01 发表:: 请问这个杂志刚投稿成功状态就成为Under Review吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559758, encodeId=5193559e5827, content=请问这个杂志刚投稿成功状态就成为Under Review吗？136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。136****9922暂无昵称 2018-07-26 00:00:00 发表: 刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=136****9922暂无昵称 2018-07-26 发表:: 接收率：约25% 审稿时间：约2个月刚刚中了一篇，好开心。糖尿病视网膜病变的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b781481343, createdName=nfm123, createdTime=Wed Aug 01 00:00:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559592, encodeId=b74c5595923b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：刚刚中了一篇，好开心。糖尿病视网膜病变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d082269775, createdName=121a0c15m22暂无昵称, createdTime=Thu Jul 26 00:00:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530597, encodeId=a01753059e3a, content=投稿命中率:25.0 经验分享：刚投稿一篇，稿件号584，近2年发文290篇，推算接收率约25%。期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d8d1638454, createdName=empire253, createdTime=Wed Dec 14 16:41:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2016-12-14 empire253

投稿命中率:25.0
经验分享：刚投稿一篇，稿件号584，近2年发文290篇，推算接收率约25%。期待好运

403 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务